EUVIMEDEUVIMED entdecken
Crossref

Artificial Biosynthetic Pathways for Cell-Free Production of Raspberry Ketone and the Cardiotonic Drug Dobutamine

Yuhao Zhang, Wan-Qiu Liu, Jian Li iD

ACS Synthetic Biology · 16.10.2026 · 15 (10) · 4371-4379

DOI: 10.1021/acssynbio.6c00642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 25.09.2026. Verfasst von Yuhao Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Science and Technology, ShanghaiTech University, Shanghai201210, China. Hauptthemen laut MEDLINE: Butanones, Biosynthetic Pathways, Dobutamine, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: School of Physical Science and Technology, ShanghaiTech University, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Raspberry ketone (RK) is a high-value flavor and fragrance compound widely used in the food, beverage, and cosmetic industries. However, existing biosynthetic routes largely rely on native metabolic pathways that involve multiple enzymatic steps and exhibit limited production efficiency. Here, we designed and constructed a retrosynthesis-guided artificial biosynthetic pathway for cell-free RK production. The pathway combines an artificial aldolase (ALD) with the native benzalacetone reductase (BAR) to convert 4-hydroxybenzaldehyde and acetone into RK through only two enzymatic steps. Following optimization of enzyme architecture and reaction conditions, the system produced 1.33 mM RK with a 66% conversion yield. We further extended this platform to the synthesis of the cardiotonic drug dobutamine through a non-natural reductive amination cascade using an engineered short-chain dehydrogenase/reductase (SDR). Rational protein engineering and byproduct recycling increased dobutamine production by approximately 104-fold relative to the wild-type enzyme. Both biosynthetic modules remained robust upon scale-up from microliter to milliliter volumes, and preparative-scale synthesis enabled isolation of 19.2 mg of RK. Overall, this work establishes artificial biosynthetic pathways for the production of a plant-derived natural product and a clinically relevant drug molecule, highlighting the potential of cell-free biomanufacturing as a sustainable platform for the synthesis of value-added chemicals and pharmaceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButanonesBiosynthetic PathwaysDobutamineCardiotonic AgentsCell-Free SystemMetabolic EngineeringProtein Engineering

Stichwörter der Autor:innen

artificial biosynthetic pathwaysbiocatalysis and biotransformationcell-free productiondobutamineraspberry ketonevalue-added chemicals

Substanzen

raspberry ketoneButanonesDobutamineCardiotonic Agents

Autor:innen und Institutionen

  • School of Physical Science and Technology, ShanghaiTech University, Shanghai201210, China.
  • State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai201210, China.
  • Shanghai Clinical Research and Trial Center, ShanghaiTech University, Shanghai201210, China.

ORCID-Profile: Jian Li

Förderung

  • School of Physical Science and Technology, ShanghaiTech University
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Liu, W. Q., & Li, J. (2026). Artificial Biosynthetic Pathways for Cell-Free Production of Raspberry Ketone and the Cardiotonic Drug Dobutamine. ACS Synthetic Biology, 15(10), 4371-4379. https://doi.org/10.1021/acssynbio.6c00642

Vancouver

Zhang Y, Liu WQ, Li J. Artificial Biosynthetic Pathways for Cell-Free Production of Raspberry Ketone and the Cardiotonic Drug Dobutamine. ACS Synthetic Biology. 2026;15(10):4371-4379. doi:10.1021/acssynbio.6c00642

BibTeX
@article{Zhang2026,
  author = {Zhang, Yuhao and Liu, Wan-Qiu and Li, Jian},
  title = {Artificial Biosynthetic Pathways for Cell-Free Production of Raspberry Ketone and the Cardiotonic Drug Dobutamine},
  journal = {ACS Synthetic Biology},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {4371--4379},
  doi = {10.1021/acssynbio.6c00642}
}
Kostenlos starten →